U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
Investigational
11
Possibly Marketed Outside US
9
Other
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
Adrenergic receptor alpha-1
3
Adrenergic receptor alpha-2
3
Dopamine transporter
2
Integrin alpha-IIb/beta-3
2
Muscarinic acetylcholine receptor M1
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Highest Phase
Approved
9
Phase III
4
Phase I
3
Not Provided
1
Phase II
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
Unknown
21
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Condition
Hepatobiliary disease
3
Hypertension
3
Meniere's disease
3
Motion sickness
3
Anxiety
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Treatment Modality
Primary
17
Diagnostic
3
Palliative
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
CNS Activity
CNS Active
11
CNS Penetrant
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Originator
All-Union Scientific-Research Chemical-Pharmaceutical Institute
3
Loberg, M.D. et al.
3
GlaxoSmithKline
2
Hoffman-La Roche
2
Novartis
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Chemical
21
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CAS
21
FDA UNII
21
PUBCHEM
21
EPA CompTox
18
NCI_THESAURUS
15
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
12
Salts, Hydrates, Esters, etc.
9
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Patents
US20070116729
Showing
21 - 21
of
21
results
Search within data set
First page
Previous page
1
2
3
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
METHYLBENACTYZIUM BROMIDE
MORE DETAILS
M35Q3X4F69
Export Data
Search for Structure
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Muscarinic acetylcholine receptor M3
159
Muscarinic acetylcholine receptor M1
169
Muscarinic acetylcholine receptor M2
121
Muscarinic acetylcholine receptor M4
86
Conditions:
Gastrointestinal spasm
2
Methylbenactyzium bromide has been used as a spasmolytic for the treatment of gastrointestinal ulcer and gastrointestinal spasms.
Showing
21 - 21
of
21
results
Search within data set
First page
Previous page
1
2
3
Next page disabled
Next page disabled
